Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 438, 667-670 (1 December 2005) | doi:10.1038/nature04176; Received 25 June 2005; Accepted 31 August 2005
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
nature jobs
Account Director -India
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Basic Science Medical Educators
- Texas Tech University Health Sciences Center
- El Paso, Texas, USA
Risk of severe asthma episodes predicted from fluctuation analysis of airway function
Urs Frey1, Tanja Brodbeck1, Arnab Majumdar2, D. Robin Taylor3, G. Ian Town3, Michael Silverman4 & Béla Suki2
- Paediatric Respiratory Medicine, Department of Paediatrics, University Hospital of Berne, Inselspital 3010 Berne, Switzerland
- Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, USA
- Faculty of Medicine, Dunedin/Christchurch Schools of Medicine, University of Otago, New Zealand
- Institute for Lung Health, Leicester University, Leicester LE2 7LX, UK
Correspondence to: Urs Frey1 Correspondence and requests for materials should be addressed to U.F. (Email: urs.frey@insel.ch).
Abstract
Asthma is an increasing health problem worldwide1, but the long-term temporal pattern of clinical symptoms is not understood and predicting asthma episodes is not generally possible2, 3. We analyse the time series of peak expiratory flows, a standard measurement of airway function that has been assessed twice daily in a large asthmatic population during a long-term crossover clinical trial4. Here we introduce an approach to predict the risk of worsening airflow obstruction by calculating the conditional probability that, given the current airway condition, a severe obstruction will occur within 30 days. We find that, compared with a placebo, a regular long-acting bronchodilator (salmeterol) that is widely used to improve asthma control decreases the risk of airway obstruction. Unexpectedly, however, a regular short-acting
2-agonist bronchodilator (albuterol) increases this risk. Furthermore, we find that the time series of peak expiratory flows show long-range correlations that change significantly with disease severity, approaching a random process with increased variability in the most severe cases. Using a nonlinear stochastic model, we show that both the increased variability and the loss of correlations augment the risk of unstable airway function. The characterization of fluctuations in airway function provides a quantitative basis for objective risk prediction of asthma episodes and for evaluating the effectiveness of therapy.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Asthma genetics: waiting to exhaleNature Genetics News and Views (01 Mar 1997)
'Good' lipids for asthmaNature Medicine News and Views (01 Sep 2002)
RESEARCH
Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient airJournal of Exposure Analysis and Environmental Epidemiology Original Article
See all 21 matches for Research
